4th Symposium TECAM – abstracts

The germinal corpuscles of Santiago Ramón y Cajal. A stem cell vision 100 years ago Alfredo Martínez ico_video ico_doc
Genes, cells, imaging, molecules. Are we entering into biological golden age of cardiovascular medicine? Valentín Fuster ico_video ico_doc
From the cell to the tissue. Lights and shadows of stem cell-based cardiovascular repair. A preclinical view Doris Taylor ico_video ico_zip
From the bench to the patient. Is preclinical evidence translatable to the clinical arena? Bernard Gersh ico_video ico_doc
Cellular transplantation for the treatment of non-ischemic dilated cardiomyopathies LC Guarita-Souza ico_video ico_doc
New cells for new purposes. Use of gingival fibroblast for arterial wall repair Antoine Lafont ico_video ico_doc
Pleiotropic effects of cytokines on left ventricular remodelling and cardiovascular stem cell therapy Wojciech Wojakowski ico_video ico_doc
Skeletal myoblasts for cardiac regeneration in animal models Felipe Prosper ico_video ico_zip
Skeletal myoblasts alter myocardial infarction and inductibility of ventricular arrhythmias Patricia Lemarchand ico_video ico_doc
Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation Antoni Bayés-Genís ico_video ico_doc
Preclinical session Hüseyin Ince ico_video ico_doc
Adipose derived stem cell therapy for cardiovascular disease Kai Pinkernell ico_video ico_doc
Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after myocardial infarction Marco Valgimigli ico_video ico_doc
Safety and effectiveness of granulocyte-colony stimulating factor in advanced chronic heart failure Jacob Joseph ico_video ico_doc
Intracoronary injection of mononuclear bone marrow cells after ACUTE myocardial infarction Ketil Lunde ico_video ico_doc
Intracoronary injection of mononuclear bone marrow cells after ACUTE and OLD myocardial infarction Andreas Zeiher ico_video ico_doc
Intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES trial Hyo-Soo Kim    
Long-term follow-up of the first patients with ischemic heart failure and skeletal myoblast transplantation Philippe Menasché ico_video ico_doc
Myoblast in the clinical scenario. Is the USA experience different? Nabil Dib ico_video ico_zip
SEISMIC Phase II randomized study data Pilar Jiménez Quevedo ico_video ico_doc
Cell processing protocol for myocardial repair. Is this the clue for positive results? Stefanie Dimmeler    
Stem cell therapy for myocardial repair. Size matters? Bernardo Nadal-Ginard    
Stem cell attraction to accelerate re-endothelization process. Is this the future of drug eluting stents? Emanuele Meliga ico_video ico_zip
From Genes to metabolical products. Biological bases of individualized cardiovascular prevention and therapy Andre Terzic ico_video ico_doc
Myocardial regeneration in animal models. Reality or fantasy? ico_video ico_doc
  Bernardo Nadal-Ginard    
  Renu Virmani ico_video ico_doc
Stem cell therapy for STEMI. Is it time for a large scale clinical trial? ico_video ico_doc
  Andreas Zeiher ico_video ico_doc
  Philippe Menasché ico_video ico_doc
Stem cell delivery for cardiovascular repair. How will we do it five years from now? Bernardo Nadal-Ginard    
Diseases or individuals. Will advances in biology personalise cardiovascular medicine? Thomas F. Lüscher    
Message for the future. John Martin    
Closing Remarks. Francisco Fernandez-Aviles ico_video ico_doc